Chlorine in PDB 7b32: MST3 in Complex with MRIA7

All present enzymatic activity of MST3 in Complex with MRIA7:
2.7.11.1;

The structure of MST3 in Complex with MRIA7, PDB code: 7b32 was solved by R.Tesch, M.Rak, A.C.Joerger, S.Knapp, Structural Genomics Consortium(Sgc), with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å)	49.90 / 1.75
Space group	C 1 2 1
Cell size a, b, c (Å), α, β, γ (°)	100.042, 59.212, 61.554, 90.00, 93.95, 90.00
R / Rfree (%)	17.4 / 20.3

The binding sites of Chlorine atom in the MST3 in Complex with MRIA7 (pdb code 7b32). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the MST3 in Complex with MRIA7, PDB code: 7b32:

Chlorine binding site 1 out of 1 in the MST3 in Complex with MRIA7


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of MST3 in Complex with MRIA7 within 5.0Å range: probe atom residue distance (Å) B Occ A:Cl401 b:27.4 occ:1.00 CL1 A:SQQ401 0.0 27.4 1.0 CBE A:SQQ401 1.7 22.7 1.0 CBD A:SQQ401 2.7 23.0 1.0 CAZ A:SQQ401 2.7 20.8 1.0 CAR A:SQQ401 3.1 19.2 1.0 CG A:MET111 3.3 25.5 1.0 CAQ A:SQQ401 3.5 19.6 1.0 O A:ALA63 3.6 20.6 1.0 N A:LYS65 3.7 20.8 1.0 CB A:MET111 3.7 19.5 1.0 CB A:LYS65 3.8 19.6 1.0 C A:ALA63 3.8 18.6 1.0 CB A:ALA63 3.9 19.0 1.0 CAS A:SQQ401 3.9 18.1 1.0 CG1 A:VAL50 4.0 18.5 1.0 CBC A:SQQ401 4.0 26.2 1.0 CBA A:SQQ401 4.0 27.8 1.0 O A:ILE109 4.1 20.3 1.0 N A:ILE64 4.1 16.3 1.0 C A:ILE64 4.1 21.2 1.0 OBM A:SQQ401 4.3 19.3 1.0 CA A:LYS65 4.3 20.0 1.0 CA A:ILE64 4.4 19.3 1.0 CG2 A:VAL50 4.4 24.8 1.0 N A:MET111 4.4 19.6 1.0 CBB A:SQQ401 4.5 28.4 1.0 CA A:ALA63 4.5 16.1 1.0 C5 A:SQQ401 4.6 18.7 1.0 CA A:MET111 4.7 17.9 1.0 CE A:LYS65 4.8 21.8 1.0 O A:ILE64 4.8 20.4 1.0 CB A:VAL50 4.9 19.9 1.0 NAC A:SQQ401 4.9 15.2 1.0 C A:ILE109 4.9 22.6 1.0 SD A:MET111 4.9 33.1 1.0

R.Tesch, M.Rak, A.C.Joerger, S.Knapp, Structural Genomics Consortium (Sgc). Structure-Based Design of Selective Salt-Inducible Kinase (Sik) Inhibitors To Be Published.